Topics
Editorially Independent Content, Supported With Advertising From Astellas
March 2026 Insert | GA Fundamentals
Early Bilateral Complement Inhibition in Extrafoveal Geographic Atrophy
Daniel Su, MD, and Matthew C. Johnson, MD
January 2026 Insert | GA Fundamentals
Identifying Early Disease and Geographic Atrophy Risk Factors in AMD
Functional symptoms, imaging biomarkers, and early referral support timely detection and management of GA.
Adrienne W. Scott, MD, FASRS
November/December 2025 Insert | GA Fundamentals
Setting Expectations for Geographic Atrophy Treatment
From early- to late-stage disease, tailored conversations emphasize preservation, proactive care, and supportive strategies.
Sonia Mehta, MD
October 2025 Insert | GA Fundamentals
Treating Geographic Atrophy in Real-world Practice: A Case Example
Carl J. Danzig, MD, FASRS
July/August 2025 Insert | GA Fundamentals
Bridging the Visual Disconnect in Geographic Atrophy
Educating asymptomatic and early-stage patients on risks drives adherence to therapy.
Caesar K. Luo, MD, FASRS
March 2025 Insert | GA Fundamentals
Navigating a GA Patient’s Journey Through Clinic
Use of imaging and relevant educational supplements can help cut down on extended chair time.
Esther L. Kim, MD
January/February 2025 Insert | GA Fundamentals
Evolving the Treatment Paradigm in Geographic Atrophy: Considerations for Early Initiation of Therapy
Complement inhibitors have transformed the landscape, changing how patients with intermediate AMD are followed in the clinic.
Chirag D. Jhaveri, MD
November/December 2024 Insert | GA Fundamentals
Broadening the Scope of Complement Inhibitor Treatment
Balancing early intervention and long-term adherence, retina specialists leverage imaging and patient education to optimize geographic atrophy treatment with complement inhibitors.
Durga S. Borkar, MD, MMCi
May/June 2024 Insert | GA Fundamentals
How Do You Engage With Your Referral Network?
A collaborative approach between retina specialists and referring providers is key to diagnosing and monitoring patients with geographic atrophy.
Priya Sharma Vakharia, MD
April 2024 Insert | GA Fundamentals
Geographic Atrophy: Guiding the Conversation With Patients
Helping patients with geographic atrophy understand their disease through analogies and clear communication can empower them to make informed treatment decisions.
David S. Chin Yee, MD
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program
Free Print Subscription
Email Newsletter
Conference Calendar